Clinical trial
Safety and Tolerability Study of FG-3019 in Participants With Idiopathic…
NCT00074698 · Kyntra Bio, Industry · Completed
Key facts
| NCT number | NCT00074698 |
|---|---|
| Title | Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis |
| Official title | A Phase 1 Study of the Safety, Pharmacokinetics, and Biologic Activity of Escalating Doses of FG-3019 in Subjects With Idiopathic Pulmonary Fibrosis |
| Lead sponsor | Kyntra Bio, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Idiopathic Pulmonary Fibrosis |
| Intervention type | Drug |
| Interventions | FG-3019 |
| Enrollment | 21 |
| Start date | Dec 8, 2003 |
| Completion | May 1, 2004 |
| First posted | Dec 22, 2003 |
| Last update posted | Jul 12, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: